Strattera, the first NON-stimulant drug approved for ADHD

January 2003

Eli Lilly will soon market Strattera, the first NON-stimulant drug approved for ADHD.

Strattera (atomoxetine) will be a blockbuster...25% of all ADHD prescriptions by 2006.

There's no proof it works better than other ADHD drugs, but it's NOT a controlled substance.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

landmark NIH hypertension study will change how patients with high blood pressure are treated
Strattera, the first NON-stimulant drug approved for ADHD
Provigil (modafinil), the latest prescription "lifestyle drug"
some patients are accidentally overdosing on their methotrexate
Cardiology You'll be hearing a lot about C-reactive protein
Cardiology statins decrease the effects of Plavix
Dermatology treatments for wrinkles
Dermatology Aldara (imiquimod cream) to treat actinic keratoses
Infectious Diseases Copegus, a new ribavirin tablet for hepatitis C
Infectious Diseases how to treat gonorrhea now that Wyeth is discontinuing cefixime (Suprax)
Women's Health how to treat women with epilepsy
Natural Medicines "seals of approval" on brand name dietary supplements
Osteoporosis Forteo (teriparatide), human parathyroid hormone for treating osteoporosis
Is it legal for patients to import prescription drugs
whether a "float test" tells if a metered-dose inhaler is empty